Suzhou Zelgen Biopharmaceuticals Co., Ltd. Price (688266.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

255,580,499

(6.4919)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $45.3-96.18
  • Market Cap 25.10B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Zelin Sheng
  • IPO Date: January, 23, 2020
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 867

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation